Hostname: page-component-78c5997874-g7gxr Total loading time: 0 Render date: 2024-11-06T08:14:53.832Z Has data issue: false hasContentIssue false

Biochemical markers of depression - an up-to-date review

Published online by Cambridge University Press:  13 August 2021

A. Nobis*
Affiliation:
Department Of Psychiatry, Medical University of Białystok, Choroszcz, Poland
D. Zalewski
Affiliation:
Department Of Psychiatry, Medical University of Białystok, Choroszcz, Poland
E. Dąbrowska
Affiliation:
Department Of Psychiatry, Medical University of Białystok, Choroszcz, Poland
N. Waszkiewicz
Affiliation:
Department Of Psychiatry, Medical University of Białystok, Choroszcz, Poland
*
*Corresponding author.

Abstract

Core share and HTML view are not available for this content. However, as you have access to this content, a full PDF is available via the ‘Save PDF’ action button.
Introduction

Depression or Major Depressive Disorder (MDD) is the most prevalent psychiatric disorder and a leading cause of disability worldwide. Currently affecting around 300 million people worldwide, depression is a major clinical, emotional, and socioeconomic strain for society. There is a growing interest in the biological underpinnings of depression, which are reflected by altered levels of biomarkers.

Objectives

The aim of the study was to present an up-to-date review of potential MDD biomarkers.

Methods

PubMed, Scopus, and Web of Science databases were searched.

Results

Enhanced inflammation has been reported in MDD, as reflected by increased concentrations of inflammatory markers – interleukin-6, C-reactive protein, tumor necrosis factor-α, and soluble interleukin-2 receptor. Dysregulation of the hypothalamus-pituitary-adrenals axis, along with increased cortisol levels, have also been reported in MDD. Oxidative and nitrosative stress also plays an important role in the pathophysiology of MDD. Notably, increased levels of lipid peroxidation markers are characteristic of MDD. Kynurenine metabolites, increased glutamate and decreased total cholesterol are also features of MDD. Finally, alterations in growth factors, with a significant decrease in brain-derived neurotrophic factor and an increase in fibroblast growth factor-2 and insulin-like growth factor-1 concentrations have also been found in MDD.

Conclusions

A group of substances holds promise as reliable biomarkers for MDD. However, biomarker research in depression faces many difficulties, such as insufficient understanding of MDD etiopathogenesis, substantial heterogeneity of the disorder and low specificity of biomarkers. The construction of biomarker panels and their evaluation with use of new technologies may have the potential to overcome the above mentioned obstacles.

Disclosure

No significant relationships.

Type
Abstract
Creative Commons
Creative Common License - CCCreative Common License - BY
This is an Open Access article, distributed under the terms of the Creative Commons Attribution licence (http://creativecommons.org/licenses/by/4.0/), which permits unrestricted re-use, distribution, and reproduction in any medium, provided the original work is properly cited.
Copyright
© The Author(s), 2021. Published by Cambridge University Press on behalf of the European Psychiatric Association
Submit a response

Comments

No Comments have been published for this article.